Drug Shows Promise in Advanced Prostate Cancer When Used Before Chemotherapy
Wednesday, January 29, 2014 - 03:50
in Health & Medicine
The drug Xtandi, already on the market for post-chemotherapy use, could open a new front in its competition with Johnson & Johnson’s Zytiga.